SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group
Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
- Publisher
- Statistics Canada
- Resources
- 5
- Catalogue metadata updated
- 2025-05-26
Data overview
- Formats
- CSV, HTML, XML
- File languages
- English, French
Official sources and licences
Resources
- SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group (English, CSV) CSV
- SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group (French, CSV) CSV
- SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group (English, French, XML) XML
- Supporting Document (English, HTML) HTML
- Supporting Document (French, HTML) HTML